Type 2 Diabetes Diagnoses Emerge in Teens Months After COVID Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections Oct 14, 2024
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia News and commentary from the endocrinology world Oct 08, 2024
Should I Prescribe Liraglutide to a 6-Year-Old Patient With Obesity if FDA Approved? I anticipate benefits outweighing potential risks in only a select few situations Oct 06, 2024
Metabolic Accelerator Shows Promise for Weight Loss Side of Obesity-HFpEF Equation Benefit in symptoms, functional outcomes remains to be seen for HU6 Oct 02, 2024
Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D News and commentary from the endocrinology world Oct 01, 2024
Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopy Bowel preparation protocols appeared protective in small study Oct 01, 2024
The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs Other than staying on drug, there's no evidence-based strategy to maintain weight loss Sep 26, 2024
'Stop Ripping Us Off': Senate Goes After Ozempic-Maker Over Pricing Novo Nordisk needs to cut prices, says Sen. Bernie Sanders Sep 24, 2024
One-Year CGM Cleared; Osteoporosis Lawsuits Revived; Chemicals and Early Puberty News and commentary from the endocrinology world Sep 24, 2024
Severe Obesity on the Rise in the U.S. Nearly 10% of those surveyed reported severe obesity Sep 24, 2024
What Factors Predict Clinically Meaningful Weight Loss With GLP-1 Agonists? Researcher discusses weight outcomes for those taking semaglutide or liraglutide Sep 16, 2024 video
Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening More noteworthy research from the EASD 2024 meeting Sep 13, 2024
Direct-to-Consumer Drugs: Big Pharma's Digital Health Play Regulators will need to closely watch this new frontier Sep 13, 2024
Tirzepatide Yields Greater Weight Loss in Women Than Men But significant weight loss reported for both Sep 12, 2024
Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6 Saxenda group six times more likely to lose at least 5% of BMI Sep 10, 2024
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win News and commentary from the endocrinology world Sep 09, 2024
New Studies Fuel Debate Over GLP-1 Drugs and Suicide Risk No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials Sep 03, 2024
Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics News and commentary from the endocrinology world Sep 03, 2024
Wegovy Protects Against Deadly COVID Cases Non-cardiovascular benefits observed in SELECT trial Aug 30, 2024
T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available News and commentary from the endocrinology world Aug 27, 2024
Intermittent Fasting in Teens With Obesity Matches Calorie Restriction Similar improvements in weight loss and mental health in randomized trial Aug 26, 2024
Semaglutide Has Disproportionate Suicidality Signal, Analysis Finds Reports of suicidal ideation higher when compared to other drugs in WHO database Aug 20, 2024
Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update News and commentary from the endocrinology world Aug 20, 2024
Researchers Hit the Road to Learn Why CVD and COPD Are Rampant in the Rural South "No race is spared, although people of color fare worse," says project leader Aug 19, 2024
Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins News and commentary from the endocrinology world Aug 13, 2024
Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI News and commentary from the endocrinology world Aug 06, 2024
Prescription-Free Online Semaglutide Is Risky Business Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
Aerosmith Retires After Injury; All Zepbound Doses Now Available; Guacamole Recalled Health news and commentary gathered by ΒιΆΉ΄«Γ½ staff Aug 05, 2024
Intermittent Fasting May Improve Memory, Executive Function, Early Trial Suggests Exploratory study lays groundwork for larger trials to evaluate brain health Aug 04, 2024
New Firearm Injury Numbers; Another Indication for Semaglutide? Also in TTHealthWatch: bilateral mastectomy for breast cancer Aug 03, 2024 podcast
Semaglutide May Help Smokers Quit, Study Suggests Use for diabetes tied to fewer medical visits for tobacco use disorder versus other antidiabetics Jul 30, 2024
Faulty FreeStyle Libre 3 Sensors; Endocrine Society Merger; More Levemir Pushback News and commentary from the endocrinology world Jul 30, 2024
FDA Warns of Overdoses With Compounded Semaglutide Multi-dose vials pose complications for self-administration Jul 29, 2024
Maternal Obesity Linked to Sudden Unexpected Infant Death Researchers found a dose-dependent link but causal mechanism remains unclear Jul 29, 2024
Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues News and commentary from the endocrinology world Jul 23, 2024
People Without Diabetes Make Up Growing Share of GLP-1 Users Approximately one-fourth of new users in 2023 did not have type 2 diabetes Jul 22, 2024
Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Down News and commentary from the endocrinology world Jul 16, 2024
We've Been Here Before: The Politicization of Drug Pricing Ensuring medication access does not have to come at the cost of innovation Jul 16, 2024
Shedding Criticisms: The Real Weight of Misunderstanding Obesity Stigma and misconceptions create barriers to medication uptake Jul 14, 2024